Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway.

about

Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway.

Item

http://www.wikidata.org/entity/Q55024929

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Brusatol Enhances the Chemothe ...... a the Nrf2 Signalling Pathway.

@en

Brusatol Enhances the Chemothe ...... a the Nrf2 Signalling Pathway.

@nl

type

Item

label

Brusatol Enhances the Chemothe ...... a the Nrf2 Signalling Pathway.

@en

Brusatol Enhances the Chemothe ...... a the Nrf2 Signalling Pathway.

@nl

prefLabel

Brusatol Enhances the Chemothe ...... a the Nrf2 Signalling Pathway.

@en

Brusatol Enhances the Chemothe ...... a the Nrf2 Signalling Pathway.

@nl

P1476

Brusatol Enhances the Chemothe ...... ia the Nrf2 Signalling Pathway

@en

P2093

Bin Lou

http://www.w3.org/2001/XMLSchema#string

Chaohao Huang

http://www.w3.org/2001/XMLSchema#string

Dinglai Yu

http://www.w3.org/2001/XMLSchema#string

Fan Zhang

http://www.w3.org/2001/XMLSchema#string

Hao Chen

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Keqing Shi

http://www.w3.org/2001/XMLSchema#string

Tuo Deng

http://www.w3.org/2001/XMLSchema#string

Wen Ye

http://www.w3.org/2001/XMLSchema#string

Yukai Xiang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2.

An investigational new drug treatment program for patients with gemcitabine: results for over 3000 patients with pancreatic carcinoma.

Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.

Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.

Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage

P304

2360427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/2360427

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Mengtao Zhou

Bicheng Chen

P577

2018-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29849873

http://www.w3.org/2001/XMLSchema#string

P932

5932458

http://www.w3.org/2001/XMLSchema#string